Other Updated 2019-10-15

LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions


Hazard / Issue

Product safety

Issued by

Marketed health products

View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon Canada →